The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product
1 other identifier
interventional
12
1 country
1
Brief Summary
This study is to quantify the effect of a natural fruit extract added to a wheat product on the time needed to absorb 50% of the apparent total of available exogenous carbohydrate (RaE \* Time). In addition the different glucose fluxes will be quantified (RaE, EGP and GCR)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Jan 2016
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 20, 2016
CompletedFirst Posted
Study publicly available on registry
January 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedOctober 26, 2016
October 1, 2016
1 month
January 20, 2016
October 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
13C (13 carbon) and D-[6,6-2H2] glucose
0-6 hours
Secondary Outcomes (11)
Total blood glucose (BG)
0-2 hours and 0-4 hours
Insulin
0-2 hours and 0-4 hours
Endogenous glucose production (EGP)
0-2 hours and 0-4 hours
Glucose clearance rate (GCR)
0-2 hours and 0-4 hours
13C Metabolites of glucose (metabolomics)
0-2 hours and 0-4 hours
- +6 more secondary outcomes
Study Arms (3)
A wheat product
ACTIVE COMPARATORA wheat product (containing 2% 13C-universally-labeled wheat) with natural fruit extract added.
Control
PLACEBO COMPARATORA wheat product (containing 2% 13C-universally-labeled wheat) without natural fruit extract added.
Glucose solution
OTHERA solution of 50g glucose of which 2% 13C-universally-labeled glucose (2%) and unlabeled glucose (98%) in 250 mL water.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Caucasian male.
- Body mass index (BMI) ≥ 18.0 and ≤ 25.0 kg/m2.
- Apparently healthy: no medical conditions which might affect the study measurements including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases.
- Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/liter (i.e. 62- 110 mg/dl) at screening.
- HbA1c ≤ 6.5 % (48 mmol/mol).
You may not qualify if:
- Use of antibiotics within 3 months before Day 1; use of any other medication except paracetamol within 14 days before Day 1.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
QPS
Groningen, Hanzeplein 1, 9713 GZ, Netherlands
Study Officials
- PRINCIPAL INVESTIGATOR
Tjeerd Mensinga, MD, PhD
QPS Netherlands
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2016
First Posted
January 25, 2016
Study Start
January 1, 2016
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
October 26, 2016
Record last verified: 2016-10